N-A 3 -fluoro-4- (A 6 - (METHYLOXY) -7-A (3-MORPHOLIN-4 YLPROPYL) OXYQUINOLIN-4-YLOXY) PHENYLU-N '- (4-FLUORO-PHENYL) CYCLOPROPANE-1,1-DICARBOXAMIDE FOR TREATMENT OF CANCER

摘要

The present invention provides a compound which is represented by the following structure: which inhibits, regulates and/or modulates kinase receptors, particularly c-Met, KDR, c-Kit, flt-3 and flt-4. This compound is therefore suitable for the treatment of diseases or disorders associated with uncontrolled, abnormal and/or unwanted cellular activities.